<article>
<section>
<h1 id="header">Generation and assessment of high-quality mouse oocytes and embryos following nicotinamide mononucleotide administration</h1>
<p><time datetime="2021-01-22">Published: January 22, 2021</time></p>
<p>Yilong Miao,<sup><a href="#aff1">1</a>,<a href="#fn1">3</a></sup> Jingyue Chen,<sup><a href="#aff1">1</a>,<a href="#fn1">3</a></sup> Qian Gao,<sup><a href="#aff2">2</a></sup> and Bo Xiong<sup><a href="#aff1">1</a>,<a href="#fn2">4</a>,<a href="#fn3">5</a>,<a href="#cor1">*</a></sup></p>
<p id="aff1"><sup>1</sup>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China</p>
<p id="aff2"><sup>2</sup>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China</p>
<p id="fn1"><sup>3</sup>These authors contributed equally</p>
<p id="fn2"><sup>4</sup>Technical contact</p>
<p id="fn3"><sup>5</sup>Lead contact</p>
<p id="cor1"><sup>*</sup>Correspondence: <a href="mailto:xiongbo@njau.edu.cn">xiongbo@njau.edu.cn</a></p>
<p><span class="open-access">Open Access</span> • DOI: <a href="https://doi.org/10.1016/j.xpro.2021.100298">10.1016/j.xpro.2021.100298</a></p>
</section>
<section>
<h2 id="summary">Summary</h2>
<p>The low quality of oocytes is one of the main causes of the suboptimal reproductive outcome of female mammals with advanced maternal age. Here, we present a detailed protocol to obtain high-quality oocytes and embryos from aged mice by nicotinamide mononucleotide (NMN) administration. We also describe fluorescence staining procedures to assess the organelle dynamics in oocytes, and <i>in vitro</i> fertilization and embryo culture systems to evaluate the influence of NMN on the fertilization ability and embryonic development potential.</p>
<p>For complete information on the use and execution of this protocol, please refer to <a href="#bib13">Miao et al. (2020)</a>.</p>




<div class="highlights">
<h3>Highlights</h3>
<ul>
<li>A protocol for harvest of high-quality mouse oocytes and embryos by NMN treatment</li>
<li>Fluorescence staining and confocal imaging to evaluate oocyte quality</li>
<li>
<i>In vitro</i> fertilization and embryo culture procedures to assess embryo quality</li>
</ul>
</div>
<div class="graphical-abstract">
<h3>Graphical Abstract</h3>
<figure><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-GA.jpg" alt="GraphicalAbstract.jpg"></figure>
</div></section>
<section>
<h2 id="before-you-begin">Before you begin</h2>
<h3 id="sec1.1">Preparation of NMN solution</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 10 min</div>
<ol>
<li>Dissolve NMN in sterile PBS to prepare the solution at concentration of 100 mg/mL.</li>
</ol>
<h3 id="sec1.2">NMN administration and oocyte superovulation</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 10 days</div>
<ol start="2">
<li>Intraperitoneally inject 14–16-month-old ICR female mice with 0.1 mL of PBS (control) or 100 mg/mL NMN (200 mg/kg body weight per day) using a 1 mL syringe with 20G needle for 10 consecutive days.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> The administration dose should be optimized by gradient test (0–1,000 mg/kg body weight) according to the age and strain of the mice. (See <a href="#sec6.1">Troubleshooting 1</a>)</div>
<ol start="3">
<li>At the 8<sup>th</sup> day, intraperitoneally inject female mice with 10 IU pregnant mare serum gonadotropin (PMSG).</li>
<li>After 44–48 h, intraperitoneally inject female mice with 10 IU human chorionic gonadotropin (hCG).</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> 5 IU of PMSG and hCG are usually injected for superovulation in young mice. Aged mice are not sensitive to the gonadotrophins, and thus injection dose may need to be increased to 10 IU when necessary. (See <a href="#sec6.3">Troubleshooting 2</a>)</div>
</section>
<section>
<h2 id="key-resources-table">Key resources table</h2>
<table id="krt">
<thead>
<tr>
<th>REAGENT or RESOURCE</th>
<th>SOURCE</th>
<th>IDENTIFIER</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3">Antibodies</td>
</tr>
<tr>
<td>Mouse monoclonal anti-α-tubulin-FITC</td>
<td>Sigma-Aldrich</td>
<td>Cat# F2168; RRID: AB_2827403</td>
</tr>
<tr>
<td colspan="3">Chemicals, peptides, and recombinant proteins</td>
</tr>
<tr>
<td>Nicotinamide mononucleotide</td>
<td>Sigma-Aldrich</td>
<td>Cat# N3501</td>
</tr>
<tr>
<td>M2 medium</td>
<td>Sigma-Aldrich</td>
<td>Cat# M7167</td>
</tr>
<tr>
<td>M16 medium</td>
<td>Sigma-Aldrich</td>
<td>Cat# M7292</td>
</tr>
<tr>
<td>Albumin from bovine serum</td>
<td>Sigma-Aldrich</td>
<td>Cat# A1933</td>
</tr>
<tr>
<td>Mineral oil</td>
<td>Sigma-Aldrich</td>
<td>Cat# M8410</td>
</tr>
<tr>
<td>Triton X-100</td>
<td>Sigma-Aldrich</td>
<td>Cat# V900502</td>
</tr>
<tr>
<td>Tween 20</td>
<td>Sigma-Aldrich</td>
<td>Cat# V900548</td>
</tr>
<tr>
<td>Tyrode's solution, acidic</td>
<td>Sigma-Aldrich</td>
<td>Cat# T1788</td>
</tr>
<tr>
<td>Lens Culinaris Agglutinin (LCA)-FITC</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# L32475</td>
</tr>
<tr>
<td>Phosphate-buffered saline</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# 20012027</td>
</tr>
<tr>
<td>Hoechst 33342</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# H3570</td>
</tr>
<tr>
<td>Propidium iodide</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# P3566</td>
</tr>
<tr>
<td>EmbryoMax Human Tubal Fluid (HTF) medium</td>
<td>Millipore</td>
<td>Cat# MR-070-D</td>
</tr>
<tr>
<td>EmbryoMax KSOM medium</td>
<td>Millipore</td>
<td>Cat# MR-106-D</td>
</tr>
<tr>
<td>4% paraformaldehyde</td>
<td>Santa Cruz Biotechnology</td>
<td>Cat# 281692</td>
</tr>
<tr>
<td>Pregnant mare's serum gonadotropin (PMSG)</td>
<td>Jianchun (Nanjing, China)</td>
<td>Cat# A006</td>
</tr>
<tr>
<td>Human chorionic gonadotropin (HCG)</td>
<td>Jianchun (Nanjing, China)</td>
<td>Cat# A001-2</td>
</tr>
<tr>
<td colspan="3">Critical commercial assays</td>
</tr>
<tr>
<td>MitoTracker Red CMXRos</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# M7512</td>
</tr>
<tr>
<td>Annexin V-FITC Apoptosis Detection Kit</td>
<td>Beyotime (Hangzhou, China)</td>
<td>Cat# C1062</td>
</tr>
<tr>
<td>Reactive Oxygen Species Detection Kit</td>
<td>Jiancheng (Nanjing, China)</td>
<td>Cat# E004</td>
</tr>
<tr>
<td colspan="3">Experimental models: organisms/strains</td>
</tr>
<tr>
<td>ICR mice</td>
<td>Animal Core Facility of Nanjing Medical University</td>
<td>N/A</td>
</tr>
<tr>
<td colspan="3">Other</td>
</tr>
<tr>
<td>Stereo microscope</td>
<td>Olympus</td>
<td>SZ-61</td>
</tr>
<tr>
<td>CO<sub>2</sub> incubator</td>
<td>Thermo Fisher Scientific</td>
<td>HERAcell 150i</td>
</tr>
<tr>
<td>Heating stage</td>
<td>CBL Photoelectron Technology</td>
<td>Model 100</td>
</tr>
<tr>
<td>Fine-tip forceps</td>
<td>Rhino</td>
<td>SW14</td>
</tr>
<tr>
<td>Glass slide</td>
<td>Citoglas</td>
<td>Cat# 7105P</td>
</tr>
<tr>
<td>35 mm Petri dish</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# 121V</td>
</tr>
<tr>
<td>ProLong Gold antifade mountant</td>
<td>Thermo Fisher Scientific</td>
<td>Cat# P10144</td>
</tr>
</tbody>
</table>
</section>
<section>
<h2 id="materials-and-equipment">Materials and equipment</h2>
<h3 id="sec2.1">NMN solution</h3>
<table id="undtbl1">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>NMN</td>
<td>100 mg/mL</td>
<td>1 g</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>10 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store at 4°C and warm to 20°C–25°C before use.</div>
<h3 id="sec2.2">Gonadotrophins</h3>
<p>PMSG is prepared as below.</p>
<table id="undtbl2">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>PMSG</td>
<td>5 IU/0.1 mL</td>
<td>5,000 IU</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>100 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store in single-use aliquots of 1 mL at −20°C and warm to 20°C–25°C before use.</div>
<p>hCG is prepared as below.</p>
<table id="undtbl3">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>hCG</td>
<td>5 IU/0.1 mL</td>
<td>10,000 IU</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>200 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store in single-use aliquots of 1 mL at −20°C and warm to 20°C–25°C before use.</div>
<h3 id="sec2.3">Hyaluronidase solution</h3>
<table id="undtbl4">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Hyaluronidase</td>
<td>0.1%</td>
<td>10 mg</td>
</tr>
<tr>
<td>M2 medium</td>
<td>n/a</td>
<td>10 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store in single-use aliquots of 1 mL at −20°C and warm to 37°C before use.</div>
<h3 id="sec2.4">Membrane-permeabilized solution (MPs)</h3>
<p>Immunofluorescence (IF) MPs is prepared as below.</p>
<table id="undtbl5">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>10% Triton X-100</td>
<td>0.5%</td>
<td>0.5 mL</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>9.5 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store at 4°C and warm to 20°C–25°C before use.</div>
<h3 id="sec2.5">Washing buffer</h3>
<p>IF washing buffer is prepared as below.</p>
<table id="undtbl6">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tween 20</td>
<td>0.1%</td>
<td>10 μL</td>
</tr>
<tr>
<td>10% Triton X-100</td>
<td>0.01%</td>
<td>10 μL</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>9.98 mL</td>
</tr>
</tbody>
</table>
<p>Dye staining washing buffer is prepared as below.</p>
<table id="undtbl7">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>BSA</td>
<td>0.1%</td>
<td>0.01 g</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>10 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store at 4°C and warm to 20°C–25°C before use.</div>
<h3 id="sec2.6">Blocking buffer</h3>
<p>IF blocking buffer is prepared as below.</p>
<table id="undtbl8">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>BSA</td>
<td>1%</td>
<td>0.1 g</td>
</tr>
<tr>
<td>Tween 20</td>
<td>0.1%</td>
<td>10 μL</td>
</tr>
<tr>
<td>10% Triton X-100</td>
<td>0.01%</td>
<td>10 μL</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>9.98 mL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Store at 4°C and warm to 20°C–25°C before use.</div>
<h3 id="sec2.7">Fixative</h3>
<p>Fixative for chromosome spreading is prepared as below.</p>
<table id="undtbl9">
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
<th>Amount</th>
</tr>
</thead>
<tbody>
<tr>
<td>4% paraformaldehyde</td>
<td>1%</td>
<td>250 μL</td>
</tr>
<tr>
<td>10% Triton X-100</td>
<td>0.15%</td>
<td>15 μL</td>
</tr>
<tr>
<td>Sterile PBS</td>
<td>n/a</td>
<td>735 μL</td>
</tr>
</tbody>
</table>
<div class="note">
<span class="note-title">Note:</span> Prepare just before use, and adjust pH to 9.2.</div>
<h3 id="sec2.8">Human tubal fluid (HTF) medium</h3>
<p>Two drops of 300 μL HTF for sperm capacitation and several drops of 50 μL HTF for fertilization are made in a dish with 35 mm diameter, covered with mineral oil and equilibrated in the incubator at 37°C with atmosphere of 5% CO<sub>2</sub> for 12–16 h before use (<a href="#fig1">Figure 1</a>).</p>
<figure id="fig1"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig1.jpg" alt="Fig1.jpg">
<figcaption>
<div class="figcaption-title">Figure 1. Preparation of media for sperm capacitation and fertilization</div>
<p>Two drops of 300 μL HTF for sperm capacitation and one drop of 50 μL HTF for fertilization are made in a dish with 35 mm diameter, covered with mineral oil.</p>
</figcaption>
</figure>
<h3 id="sec2.9">Potassium simplex optimized medium (KSOM) medium</h3>
<p>One drop of 50 μL KSOM for <i>in vitro</i> embryo culture is made in a dish with 35 mm diameter, covered with mineral oil and equilibrated in the incubator at 37°C with atmosphere of 5% CO<sub>2</sub> for 12–16 h before use.</p>
<h3 id="sec2.10">Equipment</h3>
<p>Turn on the stereo microscope and the heating stage (37°C) 5 min ahead of time. Prepare fine-tipped forceps, mouth pipette, and sterile alcohol cottons (<a href="#fig2">Figure 2</a>).</p>
<figure id="fig2"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig2.jpg" alt="Fig2.jpg">
<figcaption>
<div class="figcaption-title">Figure 2. The equipment used for collection of mouse sperm and oocytes</div>
</figcaption>
</figure>
</section>
<section>
<h2 id="step-by-step-method-details">Step-by-step method details</h2>
<h3 id="sec3.1">Collection of ovulated oocytes</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 20 min</div>
<p>Before starting:</p>
<ul>
<li>Pre-warm M2 medium to 37°C before use.</li>
<li>Prepare 1 mg/mL hyaluronidase with M2 medium in advance, and warm it up to 37°C for use.</li>
</ul>
<ol>
<li>Sacrifice the mice by cervical dislocation after 12–14 h of hCG injection.
<div class="critical">
<span class="critical-title">Critical:</span> The timing to sacrifice the mice after hCG injection is important because it greatly affects the number of oocytes harvested from the oviduct.</div>
</li>
<li>Hold and cut the oviduct between ovary and uterus out of mice, and place it into M2 medium in the dish on the heating stage.</li>
<li>Release ovulated oocytes in M2 medium by tearing a hole in the ampulla of the oviduct with fine-tipped forceps (<a href="#fig3">Figure 3</a>).
<figure id="fig3"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig3.jpg" alt="Fig3.jpg">
<figcaption>
<div class="figcaption-title">Figure 3. Representative image of cumulus-oocyte complexes (COCs) in the ampulla of oviduct</div>
<p>COCs can be seen in the swollen and translucent ampulla.</p>
</figcaption>
</figure>
</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The ampulla is swollen and translucent such that the oocytes are visible. Be careful not to damage the oocytes by forceps. The heating stage (37°C) should be used to maintain temperature during oocyte manipulation.</div>
<ol start="4">
<li>Remove cumulus cells surrounding oocytes by brief incubation in 1 mg/mL hyaluronidase and then wash oocytes in fresh M2 medium on the heating stage.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Do not exceed 3 min exposure to hyaluronidase as it will damage the oocytes.</div>
<p>Following oocyte collection and fertilization, the effect of NMN supplementation on oocyte and embryo quality can be assessed by 1) Antibody staining and confocal microscopy, go to step 5; 2) Dye staining and confocal microscopy, go to step 12; 3) Chromosome spreading, go to step 15; 4) Sperm binding assay, go to step 21; 5) <i>In vitro</i> fertilization and embryo culture, go to step 26.</p>
<h3 id="sec3.2">Antibody staining and confocal microscopy</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 1–1.5 days</div>
<ol start="5">
<li>Fix 20–30 oocytes in 4% paraformaldehyde (PFA)/PBS (pH 7.4) at 20°C–25°C for 30 min.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> It is better to prepare the fixation solution just before use if needed.</div>
<ol start="6">
<li>Permeabilize oocytes in IF MPs at 20°C–25°C for 20 min.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> Longer time of permeabilization will damage the oocytes.</div>
<ol start="7">
<li>Block oocytes in IF blocking buffer at 20°C–25°C for 1 h.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> This step will reduce the background of the nonspecific binding of the primary antibody.</div>
<ol start="8">
<li>Incubate oocytes with primary antibodies in the blocking buffer at 4°C for 12–16 h.</li>
</ol>
<div class="alternatives">
<span class="alternatives-title">Alternatives:</span> For some primary antibodies, oocytes can be incubated at 37°C for 4 h. In this case, the background of images might be higher.</div>
<div class="note">
<span class="note-title">Note:</span> The recommended antibody concentration: α-tubulin-FITC (1:200), LCA-FITC (1:100).</div>
<ol start="9">
<li>Wash oocytes in IF washing buffer, and then incubate them with the corresponding secondary antibodies at 20°C–25°C for 1 h.</li>
<li>Counterstain oocytes with Hoechst 33342 (10 μg/mL) at 20°C–25°C for 10 min.</li>
<li>Mount 10 oocytes in 2 μL of antifade mountant on the microscope slides and seal by coverslip with lanolin. Acquire images under the laser scanning confocal microscope immediately after mounting or store the slide at −20°C.</li>
</ol>
<h3 id="sec3.3">Dye staining and confocal microscopy</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 1.5–2 h</div>
<ol start="12">
<li>Incubate oocytes in M16 medium containing 500 nM cell permeant MitoTracker Red CMXRos, 2 μM MitoProbe JC-1, 10 μM dichlorofluorescein diacetate (DCFHDA), or 10% Annexin-V-FITC at 37°C with 5% CO<sub>2</sub> for 30 min for active mitochondrion staining, mitochondrial membrane potential assessment, DCFH staining, and Annexin-V staining, respectively.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The process of dye staining should be completed in dark to avoid the fluorescence quenching.</div>
<ol start="13">
<li>Wash oocytes three times in 0.1% BSA/PBS.</li>
<li>Mount 10 oocytes in 2 μL of antifade mountant on the microscope slides and seal by coverslip with lanolin. Acquire images under the laser scanning confocal microscope immediately after mounting or store the slide at −20°C.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> For the measurement of fluorescence intensity, acquire images from both control and treated oocytes by following the same staining procedure and setting up the same imaging parameters of the confocal microscope. Apply Image J (NIH, Bethesda, MD, USA) to define a region of interest (ROI) in the images, and determine the average fluorescence intensity per unit area within the ROI. Compare the final average intensities between aged and NMN-supplemented groups.</div>
<h3 id="sec3.4">Chromosome spreading</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 1–1.5 h</div>
<ol start="15">
<li>Warm acidic Tyrode's solution (pH 2.5) and M2 medium to 37°C.</li>
<li>Transfer oocytes into 50 μL Tyrode's solution for 30 s to remove the zona pellucida (ZP).</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> Too little exposure to the solution will not remove the ZP completely, which will prevent the oocytes from bursting and chromosomes from spreading. Too much exposure will damage and kill the oocytes. Watching the ZP dissolve under the dissection microscope can aid in optimizing the exposure time.</div>
<div class="critical">
<span class="critical-title">Critical:</span> Using fresh Tyrode's solution is critical, as its function declines with age. Use a fresh well of Tyrode's solution for each group of oocytes to ensure uniform digestion of the ZP. Tyrode's solution should be aliquoted and stored at −20°C.</div>
<ol start="17">
<li>Wash the oocytes by transferring into warmed M2 medium immediately after ZP removal.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Be careful when transferring, as oocytes will easily stick together and to the glass pipette following removal of the ZP. Addition of 0.2% polyvinylpyrrolidone in the medium helps to prevent the oocytes from sticking.</div>
<ol start="18">
<li>Recover oocytes in M2 medium for 10 min at 37°C in a 5% CO2 incubator, and then transfer them with as little M2 medium as possible into one drop of fixative on the microscope slide.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The transfer should be done within 30 s, using a microscope without a heating stage.</div>
<ol start="19">
<li>Observe oocyte dissolution under the microscope and leave the slide to air dry at 20°C–25°C for 30 min.</li>
<li>After air drying, stain the chromosomes with propidium iodide (PI) for 10 min and acquire images under the laser scanning confocal microscope.</li>
</ol>
<h3 id="sec3.5">Sperm binding assay</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 2–2.5 h</div>
<p>Before starting:</p>
<ul>
<li>Equilibrate HTF in the incubator for 12–16 h before use.</li>
</ul>
<ol start="21">
<li>Release sperm by slicing the cauda epididymides (<a href="#fig4">Figure 4</a>) from 3-month-old male mice (sacrificed by cervical dislocation) with fine-tipped forceps in HTF medium, followed by 1 h of capacitation at 37°C in a 5% CO<sub>2</sub> incubator.
<figure id="fig4"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig4.jpg" alt="Fig4.jpg">
<figcaption>
<div class="figcaption-title">Figure 4. Representative image of male reproductive system in the mouse</div>
<p>Matured sperm can be collected from cauda epididymis.</p>
</figcaption>
</figure>
</li>
<li>Calculate sperm concentration by computer-assisted sperm analysis system, and add 4 × 10<sup>5</sup>/mL capacitated sperm to 100 μL HTF containing 20–30 ovulated oocytes and 5 two-cell embryos at 37°C with 5% CO<sub>2</sub> for 30 min of binding.</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> Prepare two-cell embryos as a negative wash control ahead of time, as the sperm cannot bind to embryos.</div>
<ol start="23">
<li>Wash sperm binding to the ovulated oocytes with a wide-bore pipette to remove all but 2–6 sperm on the two-cell embryos (negative control).</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Watch the sperm binding to the oocytes under the dissection microscope when washing them. Too much or too little wash will affect the number of sperm binding to the oocytes.</div>
<ol start="24">
<li>Fix the oocytes with sperm in 4% PFA for 30 min, and stain them with Hoechst 33342 for 10 min.</li>
<li>Quantify the bound sperm from z projections acquired by confocal microscope.</li>
</ol>
<h3 id="sec3.6">
<i>In vitro</i> fertilization and embryo culture</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 5 days</div>
<p>Before starting:</p>
<ul>
<li>Equilibrate HTF in the incubator for 12–16 h before use.</li>
<li>Equilibrate KSOM in the incubator for 12–16 h before use.</li>
</ul>
<ol start="26">
<li>Release sperm by slicing the cauda epididymides from 3-month-old male mice with fine-tipped forceps in HTF medium, followed by 1 h of capacitation at 37°C in a 5% CO<sub>2</sub> incubator.</li>
<li>Add 4 × 10<sup>5</sup>/mL capacitated sperm to 100 μL HTF containing 20–30 ovulated oocytes at 37°C with 5% CO<sub>2</sub> for 5 h of incubation (<a href="#mmc1">Methods Video S1</a>).</li>
</ol>
<div class="note">
<span class="note-title">Note:</span> The presence of two pronuclei is scored as successful fertilization.</div>
<div class="critical">
<span class="critical-title">Critical:</span> Observe the activity of sperm before addition to the oocytes, as it is critical for the success of the fertilization. If the sperm activity is weak, release the sperm from another male mouse immediately. (See <a href="#sec6.5">Troubleshooting 3</a>)</div>
<ol start="28">
<li>Transfer the fertilized oocytes to a 96-well culture plate containing 100 μL KSOM medium covered with mineral oil at 37°C in a 5% CO<sub>2</sub> atmosphere for <i>in vitro</i> embryo culture for 4 days to the blastocysts.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Do not frequently (more than once per day) take embryos out of the incubator to observe the development during the culture, as it will greatly impact the progression of embryonic development. (See <a href="#sec6.7">Troubleshooting 4</a>)</div>
<figure id="mmc1"><video controls="controls">
    <source src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Mmc1.mp4" type="video/mp4"></source>
    Your browser does not support HTML5 video.
  </video>
<figcaption>
<div class="figcaption-title">Methods Video S1. <i>In vitro</i> fertilization assay, related to step 27</div>
<p>4 × 10<sup>5</sup>/mL capacitated sperm are incubated with the ovulated oocytes in 100 μL HTF at 37°C, 5% CO<sub>2</sub> for 5 h.</p>
</figcaption>
</figure>
</section>
<section>
<h2 id="expected-outcomes">Expected outcomes</h2>
<p>The advanced maternal age of female mammals is highly correlated to the decline of oocyte quality, which determines the reproductive performance of females (<a href="#bib1">Balkenende et al., 2020</a>; <a href="#bib6">Deng, 2012</a>; <a href="#bib10">Traub and Santoro, 2010</a>). The strategies to improve the oocyte quality and reproductive performance of females have been a hot research topic in the area of reproductive biology and medicine. Nicotinamide adenine dinucleotide (NAD<sup>+</sup>) is a coenzyme of many enzymes (<a href="#bib7">Gomes et al., 2013</a>; <a href="#bib11">Yoshino et al., 2018</a>; <a href="#bib12">Yoshino et al., 2011</a>), especially the Sirtuin family proteins and it has been implicated in a variety of biological processes such as DNA damage repair, autophagy, adaptive stress responses, genomic stability, and cell survival (<a href="#bib2">Bonkowski and Sinclair, 2016</a>; <a href="#bib3">Croteau et al., 2017</a>; <a href="#bib8">Kennedy et al., 2016</a>). Of note, the decreased NAD<sup>+</sup> levels with age across many tissues are involved in the aging-related diseases (<a href="#bib2">Bonkowski and Sinclair, 2016</a>; <a href="#bib4">Das et al., 2018</a>; <a href="#bib5">de Picciotto et al., 2016</a>). Therefore, as a precursor metabolic intermediate of NAD<sup>+</sup>, supplementation of NMN is an effective way to recover the NAD<sup>+</sup> levels and it is likely to be a feasible anti-aging intervention.</p>
<p>Here, we present an efficient protocol to generate high-quality oocytes from the aged mice by <i>in vivo</i> supplementation of NMN. In this way, a higher number of ovulated oocytes with reduced fragmentation of cytoplasm can be obtained. By fluorescence staining and imaging, key indicators of the oocytes, such as the spindle/chromosome structure, mitochondrial distribution, cortical granule dynamics, and chromosome ploidy, can be assessed. In aged oocytes, a higher frequency of disorganized spindle apparatus with misaligned chromosomes (<a href="#fig5">Figure 5</a>), aggregated clusters of mitochondria in the cytoplasm (<a href="#fig6">Figure 6</a>), discontinuous distribution of cortical granules in the cortex (<a href="#fig7">Figure 7</a>) and more or less number of chromosomes (<a href="#fig8">Figure 8</a>) will be observed. NMN supplementation is expected to restore these defects in aged oocytes (<a href="#fig5">Figures 5</a>, <a href="#fig6">6</a>, <a href="#fig7">7</a>, and <a href="#fig8">8</a>). Additional parameters of oocyte health, specifically reduced level of ROS (<a href="#fig9">Figure 9</a>) and limited occurrence of apoptosis (<a href="#fig10">Figure 10</a>), in NMN-supplemented oocytes can also be evaluated. Moreover, since the decline of oocyte quality is reflected in the impairment of fertilization ability as well (<a href="#bib9">Miao et al., 2018</a>), the sperm binding assay and <i>in vitro</i> fertilization assay can be used to monitor the increased number of sperm binding to the oocytes and elevated fertilization rate in NMN-supplemented oocytes. Lastly, subsequent <i>in vitro</i> embryo culture is expected to further demonstrate the enhanced early embryonic development potential of NMN-supplemented oocytes (<a href="#fig11">Figure 11</a>).</p>
<figure id="fig5"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig5.jpg" alt="Fig5.jpg">
<figcaption>
<div class="figcaption-title">Figure 5. Representative images of spindle/chromosome structure in aged and NMN+aged oocytes</div>
<p>Metaphase I oocytes are immunostained with α-tubulin to show the spindle and counterstained with PI to display the chromosome. Scale bar, 15 μm.</p>
</figcaption>
</figure>
<figure id="fig6"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig6.jpg" alt="Fig6.jpg">
<figcaption>
<div class="figcaption-title">Figure 6. Representative images of mitochondrial distribution in aged and NMN+aged oocytes</div>
<p>Metaphase I oocytes are stained with MitoTracker Red to show the mitochondria and counterstained with Hoechst to display the chromosome. Scale bar, 20 μm.</p>
</figcaption>
</figure>
<figure id="fig7"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig7.jpg" alt="Fig7.jpg">
<figcaption>
<div class="figcaption-title">Figure 7. Representative images of cortical granule dynamics in aged and NMN+aged oocytes</div>
<p>Metaphase II oocytes are stained with LCA-FITC to show the cortical granules. Scale bar, 20 μm.</p>
</figcaption>
</figure>
<figure id="fig8"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig8.jpg" alt="Fig8.jpg">
<figcaption>
<div class="figcaption-title">Figure 8. Representative images of chromosome euploidy in aged and NMN+aged oocytes</div>
<p>Chromosome spreading is performed to count the number of chromosomes. Scale bar, 5 μm.</p>
</figcaption>
</figure>
<figure id="fig9"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig9.jpg" alt="Fig9.jpg">
<figcaption>
<div class="figcaption-title">Figure 9. Representative images of ROS signals in aged and NMN+aged oocytes</div>
<p>Oocytes are stained with DCFH to show the ROS signals and countered with Hoechst to display DNA. Scale bar, 20 μm.</p>
</figcaption>
</figure>
<figure id="fig10"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig10.jpg" alt="Fig10.jpg">
<figcaption>
<div class="figcaption-title">Figure 10. Representative images of apoptotic oocytes in aged and NMN+aged groups</div>
<p>Annexin-V is stained to indicate the apoptotic status of oocytes. Scale bar, 20 μm.</p>
</figcaption>
</figure>
<figure id="fig11"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/432-Fig11.jpg" alt="Fig11.jpg">
<figcaption>
<div class="figcaption-title">Figure 11. Representative image of blastocysts developed from fertilized aged and NMN+aged oocytes</div>
<p>Aged or NMN+aged oocytes are fertilized by normal sperm <i>in vitro</i> and then cultured in KSOM for embryonic development. Scale bar, 80 μm.</p>
</figcaption>
</figure>
</section>
<section>
<h2 id="limitations">Limitations</h2>
<p>This protocol only describes an <i>in vivo</i> method by NMN injection to improve the oocyte and embryo quality from aged mice. If the researchers are planning to administrate NMN by drinking water or gavage, the optimal dose and time of NMN supplementation should be tested, because the high dose of NMN will negatively affect the oocyte and embryo quality. NMN could also be supplemented to the culture medium to promote the oocyte maturation and embryonic development <i>in vitro</i>, the concentration should be optimized.</p>
</section>
<section>
<h2 id="troubleshooting">Troubleshooting</h2>
<h3 id="sec6.1">Problem 1</h3>
<p>Failure to produce positive effects after NMN supplementation</p>
<h3 id="sec6.2">Potential solution</h3>
<p>The dose of NMN is critical for its impact on the oocyte and embryo quality. Administration of low dose probably has no beneficial effects, but administration of high dose might result in adverse outcomes. Thus, it is necessary to determine the optimal administration dose and time according to the age and strain of the mice. Furthermore, different administration methods, such as intraperitoneal injection, intravenous injection, gavage, and water feeding, might have great divergences in effective doses.</p>
<h3 id="sec6.3">Problem 2</h3>
<p>Failure to harvest ovulated oocytes from aged mice</p>
<h3 id="sec6.4">Potential solution</h3>
<p>Given that less matured oocytes can be produced in aged mice, as well as the insensitivity of aged mice to the gonadotrophins, higher doses of PMSG and hCG might be needed for maximum superovulation of oocytes. Besides, make sure to collect the oocytes 12–14 h after hCG injection, the inappropriate timing would decrease the number of superovulated oocytes.</p>
<h3 id="sec6.5">Problem 3</h3>
<p>Low fertilization rate</p>
<h3 id="sec6.6">Potential solution</h3>
<p>The sperm should be released from male mice with the age of at least 10-week-old, otherwise it always leads to the impaired fertilization. The capacitation step is also critical for sperm to acquire the fertilizing ability. Afterwards make sure the sperm swim progressively and that the number of sperm used for fertilization is optimal (2–4 × 10<sup>5</sup>/mL). If dead or motionless sperm are clustered over a half, replace by another male mouse. In addition, the ovulated oocytes should be collected just before use, as the long time incubation in the medium will result in the postovulatory aging and decreased fertilization ability of the oocytes.</p>
<h3 id="sec6.7">Problem 4</h3>
<p>Low embryonic development rate</p>
<h3 id="sec6.8">Potential solution</h3>
<p>Do not take the embryos out of the incubator frequently to observe the developmental status during <i>in vitro</i> culture, as it will maximize the ambient air exposure to damage the embryos. In addition, the shelf life of the culture medium KSOM is short, make sure to use it prior to expiration.</p>
</section>
<section>
<h2 id="references">References</h2>
<p id="bib1">Balkenende, E.M.E., van Rooij, F.B., van der Veen, F., and Goddijn, M. (2020). Oocyte or ovarian tissue banking: decision-making in women aged 35 years or older facing age-related fertility decline. Reprod. Biomed. Online <i>41</i>, 271-278. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref1">View at publisher</a></p>
<p id="bib2">Bonkowski, M.S. and Sinclair, D.A. (2016). Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat. Rev. Mol. Cell Biol. <i>17</i>, 679-690. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref2">View at publisher</a></p>
<p id="bib3">Croteau, D.L., Fang, E.F., Nilsen, H., and Bohr, V.A. (2017). NAD(+) in DNA repair and mitochondrial maintenance. Cell Cycle <i>16</i>, 491-492. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref3">View at publisher</a></p>
<p id="bib4">Das, A., Huang, G.X., Bonkowski, M.S., Longchamp, A., Li, C., Schultz, M.B., Kim, L.J., Osborne, B., Joshi, S., Lu, Y., et al. (2018). Impairment of an endothelial NAD(+)-H2S signaling network is a reversible cause of vascular aging. Cell <i>173</i>, 74-89.e20. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref4">View at publisher</a></p>
<p id="bib5">de Picciotto, N.E., Gano, L.B., Johnson, L.C., Martens, C.R., Sindler, A.L., Mills, K.F., Imai, S., and Seals, D.R. (2016). Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell <i>15</i>, 522-530. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref5">View at publisher</a></p>
<p id="bib6">Deng, M. (2012). Mechanisms of reproductive aging in the females. Sci. China Life Sci. <i>55</i>, 653-658. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref6">View at publisher</a></p>
<p id="bib7">Gomes, A.P., Price, N.L., Ling, A.J., Moslehi, J.J., Montgomery, M.K., Rajman, L., White, J.P., Teodoro, J.S., Wrann, C.D., Hubbard, B.P., et al. (2013). Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell <i>155</i>, 1624-1638. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref7">View at publisher</a></p>
<p id="bib8">Kennedy, B.E., Sharif, T., Martell, E., Dai, C., Kim, Y., Lee, P.W., and Gujar, S.A. (2016). NAD(+) salvage pathway in cancer metabolism and therapy. Pharmacol. Res. <i>114</i>, 274-283. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref8">View at publisher</a></p>
<p id="bib13">Miao, Y., Cui, Z., Gao, Q., Rui, R., and Xiong, B. (2020). Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep <i>32</i>, 107987. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/optQjwTWmzcCd">View at publisher</a></p>
<p id="bib9">Miao, Y., Zhou, C., Cui, Z., Zhang, M., ShiYang, X., Lu, Y., and Xiong, B. (2018). Postovulatory aging causes the deterioration of porcine oocytes via induction of oxidative stress. FASEB J. <i>32</i>, 1328-1337. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref9">View at publisher</a></p>
<p id="bib10">Traub, M.L. and Santoro, N. (2010). Reproductive aging and its consequences for general health. Ann. N. Y. Acad. Sci. <i>1204</i>, 179-187. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref10">View at publisher</a></p>
<p id="bib11">Yoshino, J., Baur, J.A., and Imai, S.I. (2018). NAD(+) intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. <i>27</i>, 513-528. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref11">View at publisher</a></p>
<p id="bib12">Yoshino, J., Mills, K.F., Yoon, M.J., and Imai, S. (2011). Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. <i>14</i>, 528-536. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00005-8/sref12">View at publisher</a></p>
</section>
<section>
<h2 id="article-info">Article Info</h2>
<h3>Resource Availability</h3>
<h4>Lead Contact</h4>
<p>Requests for further information and resources can be directed to the Lead Contact, Bo Xiong (<a href="mailto:xiongbo@njau.edu.cn">xiongbo@njau.edu.cn</a>).</p>
<h4>Materials Availability</h4>
<p>This study did not generate new unique reagents.</p>
<h4>Data and Code Availability</h4>
<p>This study did not generate any unique datasets or code.</p>
<h3>Acknowledgments</h3>
<p>This work was supported by the <a href="https://doi.org/10.13039/501100012166">National Key Research and Development Program of China</a> (2018YFC1003802, 2018YFC1004002), <a href="https://doi.org/10.13039/501100001809">National Natural Science Foundation of China</a> (31900592), <a href="https://doi.org/10.13039/501100004608">Natural Science Foundation of Jiangsu Province</a> (BK20190526), and <a href="https://doi.org/10.13039/501100002858">China Postdoctoral Science Foundation</a> (2019M651849).</p>
<h3>Author Contributions</h3>
<p>B.X. conceived, designed, and supervised the study; Y.M., J.C., and Q.G. conducted the experiments; Y.M. and B.X. analyzed the data; Y.M. and B.X. wrote the manuscript.</p>
<h3>Declaration of Interests</h3>
<p>The authors declare no competing interests.</p>
</section>
</article>